Ankara Üniversitesi Tıp Fakültesi Mecmuası

0365-8104 1307-5608

Ankara University

Internal Diseases

İç Hastalıkları

Hiper Lipidemili Hastalarda Tibric (Acil)(Exirel) Tedavisi

Tibric (Acil)(Exirel) Treatment in Patients with Hyper Lipidemia

Tokgöz

Güner

ANKARA UNIVERSITY, ANKARA FACULTY OF MEDICINE

12 31 1976

29 4 809 818 10 01 1976 12 31 1976

1947

Ankara Üniversitesi Tıp Fakültesi Mecmuası

In this study, Tibric Acid, which is reported to be effective in lipoprotein metabolism, was used in various types of hyperlipoproteinemia. The patients were kept under control with Placebo for six weeks and Tibric Acid for six weeks.

Bu çalışmada lipoprotein metabolizmasında etkili olduğubildirilen Tibric Acid çeşitli tipteki hiper lipoproteinemilerdekullanıldı. Hastalar altı hafta Placebo ve altı hafta Tibric Acid ile kontrol altında tutuldular.

lipid Tedavi Eksirel

lipid tedavi Exirel

1 — Bender, S.R. Clofibrate. Clin. Med. 77:33, 1970.

2 - Bielmann, P., Brown, D., Moorjani,.5., Gagne, C., Lupion, P. Tetraault L: Dose response to Tibric Acid a new hypolipidemic drug in type IV hyperlipoproteinemia. Clin. Pharmacol Ther. 17:606, 1974.

3 — Brown, D. F. Blood lipids and Lipoproteins in atherogenesis Am. J.Med. 46:691, 1969.

4 — Fredrickson, D.S. Levy, R.l. Lidgren, P.T: A comparision of heri tablo abnormal lipoprotein pattenns by two, different techni Oues. J. Clininvest. 47: 2446, 1968. , i —

5 — Noble, RAP, Electrophoretic saperation ol plasma lipoproteins in agergel, J. Lipid. Res, 9: 693, 1968.

6 — Noble, P.R., Camp Beli, R.M.: İmproved accura of in antomated İluoromatic determination of plasma trigiycerde. Clin. Chem. 16: 166, 1970.

7— Noseda, G, Sirtory, C.R.: Klinische prüfung Von <Tibric Acid», einem neuenlipid senkenden Stoff Schweiz. Med. Wsehr, 104: 1917, 1974.

8 — S5. Tabury, J.B. Wyngaarden, İB, Fredrickson, D.S. The Metabolic Basis Inherted Disease, Blakiston Division-Mo Grow hill Book 1966.

9 — Sirtory, C.R. Zoopi S., Ouarisa, B., Agradi, E.: Clinical Evaluation Of Tibric Acid (Cp 18, 524) A nev hypolipidemic agent. Pharmacol. Res. Coram. 6: 445,1974.

10 — Zelis, R., Mason, D.T. Brown Wald E, Levy, R.L. Effects of hiperlipoproteinemias and their treatment in ihe peripherel circuletion. J. Clin İnvest. 49: 1007, 1970.